ESAB vs TECH · P/E 27, rev $2.74B vs P/E 65, rev $1.22B
ESAB Corp (ESAB) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
ESAB Corp (ESAB) is a metal fabrication company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ESAB revenue for 2024-12-31 was $2.74B. Net income was $270.7M. Revenue was down 1.2% from 2023-12-31 to 2024-12-31. ESAB currently screens at market cap $7.88B and trailing P/E 26.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ESAB currently screens at market cap $7.88B and trailing P/E 26.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ESAB and TECH stock pages for the full models.
Not investment advice.